metronomic adjuvant chemotherapy with capecitabine
CZLL2025-031-001
Phase 3 small_molecule active
Quick answer
metronomic adjuvant chemotherapy with capecitabine for Nasopharyngeal Cancinoma (NPC) is a Phase 3 program (small_molecule) at Chongqing Claruvis Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chongqing Claruvis Pharmaceutical Co.,
- Indication
- Nasopharyngeal Cancinoma (NPC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active